Most of these drugs produced by compounding pharmacies have been sold to patients via telehealth companies such as Ro, Sesame, Hims & Hers, and even Weight Watchers at a substantial discount ($200-300/month compared to the Wegovy list price of about $1,350/month). In the US, he added, We can expect at least 15 new AOM [anti-obesity medications] drugs on the market within the next five years
We work with you to see whats the least amount of the medication needed to support you in maintaining your best health. Who Might Consider Microdosing GLP-1s (and Who Shouldnt) GLP-1s in general are typically recommended and usually only covered by insurance for people with obesity (defined as a BMI greater than 30) as well as those with a BMI greater than 27 and one or more weight-related conditions such as high blood pressure, type 2 diabetes, or high cholesterol
Retatrutide GLP-3 is not a drug, supplement, or food product, and is not for human consumption, veterinary use, or medical applications
2019 Aug 29;381(9):841-51.
Contains compounds that slow motility in susceptible individuals